Walleye Capital
PRAH

Walleye Capital’s PRA Health Sciences, Inc. PRAH Stock Holding History

Walleye Capital’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,900
Closed -$322K – 1965
2019
Q4 		$322K Sell
2,900
-1,800
-38% -$185K 0.02% 890
2019
Q3 		$466K Buy
4,700
+1,400
+42% +$139K 0.03% 793
2019
Q2 		$327K Sell
3,300
-6,500
-66% -$620K 0.04% 694
2019
Q1 		$1.08M Buy
+9,800
New +$1.02M 0.18% 140

Other funds holding PRAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Walleye Capital's PRAH Position: Q2 2021 in Review

Walleye Capital sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 21,808 shares — an estimated $3.34K sold.

Walleye Capital first reported a position in PRAH in Q1 2019 and held it in 6 quarters. The position peaked at $159K in Q1 2019. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Walleye Capital reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Walleye Capital sold 21,808 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $3.34K.
  • Walleye Capital first reported a position in PRA Health Sciences, Inc. in Q1 2019 and held it in 6 quarters.
  • Walleye Capital's PRA Health Sciences, Inc. position peaked at $159K in Q1 2019.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Walleye Capital's 13F filing for Q2 2021, filed 16 Aug 2021.